Research

Apply to internal competition // Limit: 2* // Tickets Available: 2

*The first submission may address any cancer type. A second submission is allowed but only for a translational or clinical stage project that primarily focuses on one of the following four cancer types: upper GI, glioblastoma, triple-negative breast cancer, or pancreatic cancer.

The University of Arizona Cancer Center (UACC) is coordinating this limited submission. For more information please contact: UACC-PreAward.

Purpose of the Award
The Mark Foundation Endeavor Awards support collaborative research projects that bring together investigators with diverse areas of expertise to tackle challenges in the prevention, diagnosis, and treatment of cancer. These grants are awarded to teams of three or more investigators to generate and integrate data from diverse lines of research and transform those insights into advances for cancer patients that could not be achieved by individual efforts. Basic, translational, and clinical projects are eligible. The project must seek to address an overarching, urgent scientific question. We welcome projects addressing substantial unmet needs in any type of cancer. We particularly encourage teams with innovative ideas for therapeutic strategies for upper GI, glioblastoma, triple-negative breast cancer, and pancreatic cancer to consider applying in this round.

Apply to Internal Competition // Limit: 3 // Tickets Available: 3

The mission of The G. Harold and Leila Y. Mathers Foundation is to advance knowledge in the life sciences by sponsoring scientific research that will benefit mankind. The foundation’s grants program seeks to support basic science, ideally with potential translational applications. Immunology, microbiome, genomics, structural biology, cellular physiology, neuroscience, etc., are some noteworthy examples of current research support.

For many years the Foundation has enjoyed special recognition in the research community for supporting “basic” scientific research, realizing that true transformative breakthroughs usually occur after a thorough understanding of the fundamental mechanisms underlying natural phenomena. More recently, and with the advent of newer investigative methodologies, technology, and tools, the Foundation now embraces innovative translational research proposals.

The grant duration must be three years. The budget should be reasonable based on the aims of the project. Indirect costs may not exceed 10%. Preliminary Budgets are required during the LOI phase. A detailed budget justification is not required until the proposal phase. The Foundation’s grant award is not intended to be utilized for purchasing capital equipment (“bricks-and-mortar”) for the lab and is intended only to support the actual investigation. The Foundation assumes and expects that capital equipment must be provided by the research institution or university.

Application Guidance:

• Grant budgets cannot exceed $600-750K
• The Foundation primarily supports basic science, ideally with potential translational applications.
• Immunology, microbiome, genomics, structural biology, cellular physiology, neuroscience, etc., are some noteworthy examples of current research support.
• Covid-19-related research projects (aims or sub-aims) will not be considered for support.
• Medical imaging technology-related projects and/or electrical engineering technology development projects will not be considered for support.
• Plant Biology Research, Oceanography, Space Exploration. and Global warming-related research will not be considered for support.
• As technology continues to advance, it is apparent that investigations in the area of basic science and translational research may become more and more reliant on collaborative, interdisciplinary projects. It is important to note that any interdisciplinary project proposals may require additional information regarding the collaborator(s)’ achievements and relevant expertise.
• Feedback for declined LOI Requests will not be provided; LOIs or Formal Proposals that have been declined should not be resubmitted at a later date for consideration.
• Renewal applications for the same or related research will not be accorded priority consideration. It is strongly advised that any re-application for grant renewal consider a new direction based on prior research or emphasize some new potential translational aspects and not merely an extension of previously funded research.
• Requests for funding previously federally supported research and/or applications pending federal approval will not be accorded priority consideration.
• Requests for support of clinical trials or drug discovery will not be approved. The Foundation will not support projects which we consider pre-clinical drug development.

Fall 2025

Nominations and Portal Registration due date: September 19, 2025 (Friday, 8 PM EST (5 PM PST)
Nominations can be submitted beginning August 1, 2025.

Due date for LOI applications: October 3, 2025 (Friday, 8 PM EST (5 PM PST) 
Applicants notified of proposal invitation or LOI rejection within one month of the due date. 

Due date for invited formal proposals: December 12, 2025 (Friday, 8 PM EST (5 PM PST) 
Applicants are notified of proposal approval or rejection within 2 ½ months of the due date. 

 *Late nominations and/or registrations will not be approved.
 

Limit: 1 // Tickets Available: 0 

J. Stevens Aubrey (Communications) 

Summary
The Huo Family Foundation invites applications for special projects. These larger and longer-term research awards would allow researchers of all career stages, collaborating as a multi-disciplinary team with different expertise and skills, to take an integrated approach to tackle the more difficult questions in this domain. 

Proposals should be tackling key questions within the broad topic of the effects of usage of and exposure to digital technologies on brain development and function (including physiological responses), social behaviour and interactions, and mental health of children and young people.

Awarded research grants in this area can be held at colleges, universities and research institutes in the UK and in the US.

We are keen to support multi-disciplinary work. These teams may consist of several group leaders from one institution, or different institutions in the UK and the US. 

Eligibility 
PLEASE NOTE WE WILL CONSIDER ONLY ONE SPECIAL PROJECT PROPOSAL FROM EACH LEAD INSTITUTION. THE LEAD INSTITUTION IS THE COLLEGE, UNIVERSITY OR RESEARCH INSTITUTE WHERE THE LEAD APPLICANT IS LOCATED. 

Limit: 1 // Tickets Available: 0

J. Burgess (Public Health)

Executive Summary
The focus of the Fiscal Year (FY) 2024 Fire Prevention and Safety (FP&S) Grant Program (hereafter referred to as the FP&S Program) is to enhance the safety of the public and firefighters with respect to fire and fire-related hazards. The FP&S Program provides grants directly to eligible entities for fire prevention programs and firefighter health and safety research and development.

Eligibility
The maximum number of applications that can be submitted is: 1. One application per eligible entity, per activity (up to one application under the FP&S Activity (not eligible) and up to one application under the R&D Activity)

Each application may include up to three projects. Each project withinan application must be presented separately as a free-standingproposal. Each project requires its own separate supporting budget and narrative statement.

If an applicant submits two or more applications for the same activity, both applications may be disqualified. 

• This is different from when an entity is applying on behalf of other organizations that are agencies or instrumentalities of the applicant (e.g., multiple fire departments under the same county, city, borough, parish, or other municipality)
• In that situation, the applicant may request similar or the same costs as long as the application clearly states which costs (including quantities) are for which agency/instrumentality
• This is permissible even if that entity submits multipleapplications across regional versus direct applications

Limit: 1 // Tickets Available: 0

K. Huntoon (Neurosurgery)

For the V Foundation V Scholar Grant 2025 funding opportunity, the University of Arizona Cancer Center (UACC) can nominate one applicant.

For more information please contact: UACC-PreAward.

Purpose of Award:

The UACC is seeking nominations for the V Scholar Grant call which supports adult cancer research. This award supports tenure-track faculty early in their cancer research career by funding projects that are either laboratory-based fundamental research or translational research. Emphasis for this grant mechanism is on supporting exceptional early career investigators at the Assistant Professor stage to be better positioned to leverage large R01 or similar sustaining grants.

Research on ANY adult cancer type will be funded in this call. Research areas not included in this scope are epidemiology, behavioral science, and health services research.

Applicant Eligibility:

Nominee must meet all of the following criteria by the nomination due date:

• Nominated by their Cancer Center Director or similar high ranking research official.
• Employed at a non-profit research institution (e.g., 501c3, Section 170).
• Either a US Citizen or a permanent legal resident in the US.
• Possess at least 2 years post-doctoral (MD or PhD) fellowship training. For MDs, a minimum of one year is acceptable if only one year is required for their specialty.
• Clinical scientists are eligible if the research institution demonstrates that it will fully support the research applicant (e.g., dedicated lab space, committed research time, start-up funds).
• Must be in a full-time tenure track or tenured faculty position (for e.g., must be eligible to
  apply for PI status on an R01 at your institution). Non-promotable adjunct, affiliated, temporary, part-time, or acting faculty positions are not eligible for Principal Investigator nomination.
• V Scholar applicants must have been appointed to their first full-time tenure track Assistant Professor position no more than 5 years prior to the nomination due date, and not yet promoted to Associate Professor.
  • Extensions to the 5-year limit may be given on a case-by-case basis to nominees who took parental leave (or other types of leave) during this window. Please contact grants@v.org with the following to obtain approval BEFORE submitting the nomination form:
    • Appointment start date
    • Length of leave
    • Institutional tenure clock stoppages/extensions, if applicable

Limit: 1 // Tickets Available: 0

S. Ehsani (University of Arizona Cancer Center)

For the V Foundation Breast Cancer Research Game-Changer Grant 2025 funding opportunity, the University of Arizona Cancer Center (UACC) can nominate one applicant.

For more information please contact: UACC-PreAward.

Purpose of Award:

This request for applications will support breast cancer research specifically at the University of Arizona Cancer Center. Hooters of America, LLC raised these funds through their local franchisees, for the 2024 “Give A Hoot” in the fight against breast cancer campaign and donated them to the V Foundation to support programs at regional cancer centers for breast cancer research. For these raised funds, the University of Arizona Cancer Center was selected as the designated recipient of regional funds in the amount of $186,000. This request for applications is specifically for Breast Cancer Research.

Applicant Eligibility:

• Nominee must meet all of the following criteria by the nomination due date:
  • Employed at the nominating institution and nominated by their Cancer Center Director or similar high ranking research official.
  • Must be either a US Citizen or have a legal permit (temporary or permanent) to work in the US.
  • Hold a full-time faculty appointment at the Assistant Professor or Assistant Professor-equivalent level or above. Non-promotable, adjunct, affiliated, temporary, part-time or acting faculty positions are not eligible for Principal Investigator nomination.
     

Limit: 1 LOI per department

V. Lai (Psychology) 

Eligibility
Organizations may submit only one Letter of Inquiry and corresponding proposal per grant cycle. Common exceptions include proposals submitted by separate departments of large universities. 


RRF funds research that seeks to identify interventions, policies and practices to improve the well-being of older adults and/or their caregivers. Preference is given to projects aimed at generating practical knowledge and guidance that can be used by advocates, policy-makers, providers, and the aging network. Of particular interest are:

• Interventional trials; translational studies; and health services and policy research
• Projects that build on the investigator’s past studies
• Proposals that include robust dissemination plans, if appropriate, to assure that findings reach audiences positioned to act on them

Limit: 1 // Tickets Available: 0

T. Moukabary (Sarver Heart Center)

Program Overview:
The Harold S. Geneen Charitable Trust Awards Program for Coronary Heart Disease Research supports research in the area of the prevention of coronary heart disease or circulatory failure and improving care for these patients. The Program focuses on basic and translational scientific research. Clinical studies are currently ineligible.

Action Applications examining the intersection of coronary heart disease and/or congestive heart failure and COVID-19 or similar viral illnesses are highly encouraged to apply.

Eligibility:
In accordance with Mr. Geneen’s directives, the Program supports smaller, mid-sized institutions. Each invited institution may only submit one application from a full-time faculty member. Junior faculty and those with less than $500,000 in direct costs funding at the time of application, are encouraged to apply. United States citizenship is not required.

No Applicants // Limit: 1 // Tickets Available: 1 

The University of Arizona Cancer Center (UACC) can nominate one applicant for the Susan G. Komen Rising Star Researcher Award 2025 which recognizes innovative work, budding leadership and dedicated mentorship in breast cancer research and treatment.

For more information please contact: UACC-PreAward.

Purpose of Award:

This award will honor an investigator whose work has the potential to significantly impact the breast cancer field, who demonstrates strong leadership potential in the breast cancer community and who exhibits a strong commitment to trainee mentorship.

The Rising Star Researcher Award has become another marquee breast cancer research award for Susan G. Komen and complements the Brinker Awards established in 1992 to honor pioneers and distinguished investigators in basic science and clinical research.

The Rising Star Researcher Award will be given annually to:

• a breast cancer researcher from across the continuum of basic, translational, clinical, population health and implementation science research
• who is driving science that is having a substantial impact, expanding our understanding of breast cancer and/or improving breast cancer care and outcomes,
• is beginning to establish visibility and leadership in the field, beyond their scientific and/or clinical discoveries, and
• is demonstrating mentorship that is significantly impacting the education and professional development of research and/or clinical trainees.

No Applicants // Limit: 3* // Tickets Available: 3

*The University of Arizona Cancer Center (UACC) can nominate up to three applicants (one per category) for the Susan G. Komen’s Brinker Awards for Scientific Distinction 2025 which recognizes pioneering work in breast cancer research and treatment. 

For more information please contact: UACC-PreAward.

Award Categories (Limit 1 Each) 

• The Brinker Award for Scientific Distinction in Basic Science will be presented to a basic science and/or translational researcher whose scientific discoveries or novel technologies have substantively impacted our understanding of the basic biology and intrinsic molecular processes driving breast cancer to improve breast cancer care.
• The Brinker Award for Scientific Distinction in Clinical Research will be presented to a clinical researcher who has advanced new approaches for prevention, detection, diagnosis and treatment that have paved the way for new clinical and therapeutic applications and/or practice changing, patient-focused care for breast cancer.
• The Brinker Award for Scientific Distinction in Population Science will be presented to a researcher who has made pivotal advances in implementing science, cancer care delivery, health services research, epidemiology and/or developed innovative evidence-based interventions to enhance breast cancer outcomes.